Cencora (COR) Gains from Investment Securities (2025 - 2026)
Cencora's (COR) quarterly Gains from Investment Securities came in at $55.4 million in Q1 2026, up 48.01% YoY from $37.5 million in Q1 2025, and up 31.58% on a QoQ basis from $42.1 million in Q4 2025.
Cencora (COR) Gains from Investment Securities (2025 - 2026) Analysis & Trends
Cencora (COR) has 2 years of Gains from Investment Securities data on file, last reported at $55.4 million in Q1 2026.
- Quarterly Gains from Investment Securities rose 48.01% year-over-year to $55.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $154.6 million (up 312.82% YoY) and the FY2025 annual result came in at $121.7 million, changed N/A from the prior year.
- Gains from Investment Securities climbed to $55.4 million in Q1 2026, from $42.1 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $55.4 million in Q1 2026 to a low of $19.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 55.17 Mn |
| Jun 30, 2026 | 55.17 Mn |
| Mar 31, 2026 | 55.45 Mn |
| Mar 31, 2026 | 55.45 Mn |
| Dec 31, 2025 | 42.14 Mn |
| Dec 31, 2025 | 42.14 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Jun 30, 2025 | 37.46 Mn |
| Jun 30, 2025 | 37.46 Mn |
| Mar 31, 2025 | 37.46 Mn |
| Mar 31, 2025 | 37.46 Mn |